STACIE WOODS: Open Payments
NPI 1184071680 · SALEM, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$558 in 11 payments from 10 companies in 2025. Trend: 2023 $516 · 2024 $618 · 2025 $558
Food & beverage: $558
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 1 | $184 |
| Ascendis Pharma Endocrinology Inc | 1 | $113 |
| Insulet Corporation | 2 | $78 |
| Sequel Med Tech, LLC | 1 | $46 |
| Rhythm Pharmaceuticals, Inc. | 1 | $34 |
| Xeris Pharmaceuticals, Inc. | 1 | $29 |
| Abbott Laboratories | 1 | $23 |
| Amgen Inc. | 1 | $18 |
| Novo Nordisk Inc | 1 | $17 |
| Lilly USA, LLC | 1 | $16 |
Products named: MINIMED 780G, Yorvipath, Omnipod, TWIIST, IMCIVREE, RECORLEV, FREESTYLE LIBRE 3, TEPEZZA.
Industry payments across OR — which companies pay providers there.
